Nathaniel Hodoba
Neurology · Sacramento, CANPI 1588077788
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,046, 4.1 times the $256 reported in 2021.
Across 52 payments — averaging $42.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$415
- UCB, Inc.$317
- Jazz Pharmaceuticals Inc.$280
- SK Life Science, Inc.$238
- Catalyst Pharmaceuticals, Inc.$165
- Zogenix Inc.$144
- plus $676 from 15 others
What the payments were for
- Food & beverage$2,14996%
- Education$854%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 8 | $415 |
| UCB, Inc. | 7 | $317 |
| Jazz Pharmaceuticals Inc. | 3 | $280 |
| SK Life Science, Inc. | 3 | $238 |
| Catalyst Pharmaceuticals, Inc. | 6 | $165 |
| Zogenix Inc. | 2 | $144 |
| Aucta Pharmaceuticals, Inc. | 5 | $118 |
| Immedica Pharma US, Inc. | 1 | $113 |
| Acadia Pharmaceuticals Inc | 3 | $100 |
| Biocodex, Inc. | 2 | $71 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Neuropace, Inc. | 1 | $33 |
| ITF Therapeutics LLC | 1 | $28 |
| Biogen | 1 | $26 |
| Mirum Pharmaceuticals, Inc. | 1 | $25 |
| Novartis | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,234 in reported general payments places this provider in the 60th percentile of 1,996 neurology providers in California.
Other neurology in Sacramento
- Lin ZhangSacramento$328K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.